This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor 1 month ago
MarketsTrading IdeasNewsAnalyst RatingsInitiation
Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Oppenheimer analyst Rupesh Parikh initiated coverage on The Vita Coco Company, Inc. (NASDAQ:COCO) with an Outperform rating and announced a price target of $70. Vita Coco closed at $57.26 on Wednesday. See how other analysts view this stock.
- Morgan Stanley analyst Adam Kramer initiated coverage on Toll Brothers, Inc. (NYSE:TOL) with an Overweight rating and announced a price target of $159. Toll Brothers shares closed at $134.75 on Wednesday. See how other analysts view this stock.
- Northland Capital Markets analyst Greg Gibas initiated coverage on Civeo Corporation (NYSE:CVEO) with an Outperform rating and announced a price target of $42. Civeo closed at $32.79 on Wednesday. See how other analysts view this stock.
- TD Cowen initiated coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a Buy rating and announced a price target of $55. Teva shares closed at $39.60 on Wednesday. See how other analysts view this stock.
- JP Morgan analyst Priyanka Grover initiated coverage on Kura Oncology, Inc. (NASDAQ:KURA) with an Overweight rating and announced a price target of $30. Kura Oncology closed at $10.71 on Tuesday. See how other analysts view this stock.
Considering buying TOL stock? Here’s what analysts think:
Photo via Shutterstock